Lv1
10 积分 2023-02-14 加入
Discovery of the First Clinical Protein Degrader for the Treatment of Autoimmune Indications: Orally Bioavailable and Selective IRAK4 Degrader KT-474
19小时前
已完结
Recent insights of PROTAC developments in inflammation-mediated and autoimmune targets: a critical review
19小时前
已完结
A bibliometric analysis of PROTAC from 2001 to 2021
1天前
已完结
argeted protein degradation: expanding the toolbox
1天前
已完结
Development of PROTAC Degrader Drugs for Cancer
2天前
已完结
Targeted protein degradation: expanding the toolbox
3天前
已完结
Seronegative autoimmune diseases: A challenging diagnosis
1年前
已完结
Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy
1年前
已完结
Mechanisms of Fibrogenesis
1年前
已完结
A new time dimension in the fight against metastasis
1年前
已完结
皖公网安备34019202002308
